Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
Boehringer Ingelheim
Julphar
US Army
Merck
Argus Health
Chubb
Teva

Generated: April 22, 2018

DrugPatentWatch Database Preview

EDECRIN Drug Profile

« Back to Dashboard

When do Edecrin patents expire, and when can generic versions of Edecrin launch?

Edecrin is a drug marketed by Aton and is included in two NDAs.

The generic ingredient in EDECRIN is ethacrynic acid. There are thirteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethacrynic acid profile page.
Drug patent expirations by year for EDECRIN
Pharmacology for EDECRIN
Medical Subject Heading (MeSH) Categories for EDECRIN
Synonyms for EDECRIN
(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid
(2,3-Dichloro-4-(2-methylenebutyryl)phenoxy)acetic acid
(2,3-Dichloro-4-[2-methylenebutyryl]phenoxy)acetic acid
(4-(2-Methylenebutyryl)-2,3-dichlorophenoxy)acetic acid
[2,3-Dichloro-4-(2-ethylacryloyl)phenoxy]acetic acid #
[2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid
[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid
[2,3-Dichloro-4-(2-methylenebutyryl)phenoxy]acetic acid
[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid
[4-(2-Methylenebutyryl)-2,3-dichlorophenoxy]acetic acid
1gsf
2-(2,3-Dichloro-4-(2-methylenebutanoyl)phenoxy)acetic acid
2-[2,3-bis(chloranyl)-4-(2-methylidenebutanoyl)phenoxy]ethanoic acid
2-[2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid
2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid
2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid
2,3-Dichloro-4-(2-methylenebutyl)phenoxyacetic acid
2,3-Dichloro-4-(2-methylenebutyryl)phenoxy acetic acid
2,3-Dichloro-4-(2-methylenebutyryl)phenoxyacetic acid
2,3-Dichloro-4(2-methylene- butyryl)phenoxy] acetic acid
2,3-Dichloro-4(2-methylene-butyryl)phenoxy] acetic acid
2gss
58-54-8
6500-81-8 (hydrochloride salt)
A831918
AB00051988
AB00051988_20
AB00051988-19
AC1L1FKN
Acetic acid, (2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy)-
Acetic acid, (2,3-dichloro-4-(2-methylenebutyryl)phenoxy)-
Acetic acid, [2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]-
Acetic acid, [2,3-dichloro-4-(2-methylenebutyryl)phenoxy]-
Acetic acid,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]-
Acetic acid,3-dichloro-4-(2-methylenebutyryl)phenoxy]-
Acide etacrynique
Acide etacrynique [INN-French]
Acido etacrinico
Acido etacrinico [INN-Spanish]
Acidum etacrynicum
Acidum etacrynicum [INN-Latin]
AK307908
AKOS003404732
AN-16719
API0002520
AVOLMBLBETYQHX-UHFFFAOYSA-N
BDBM50186231
bmse000134
BPBio1_000086
BRD-K63630713-001-05-0
BRN 1915060
BSPBio_000078
BSPBio_002010
C-18899
C13H12Cl2O4
CAS-58-54-8
CC-27538
CCG-38915
CCRIS 4638
CHEBI:4876
CHEMBL456
CPD000058600
Crinuril
Crinuryl
CTK3J2058
D00313
D06TNL
DB00903
DivK1c_000900
DSSTox_CID_5257
DSSTox_GSID_25257
DSSTox_RID_77718
DTXSID3025257
E0526
Edecril
Edecrin (TN)
Edecrina
EINECS 200-384-1
Endecril
Etacrinic acid
Etacrynic Acid
Etacrynic acid (JP15/INN)
Etacrynic acid (JP17/INN)
Etacrynic acid [INN]
Etacrynic acid for system suitability, European Pharmacopoeia (EP) Reference Standard
Etacrynsaure
Etacynic acid
Etakrinic acid
Ethacrinic acid
Ethacrinique (acide)
Ethacryinic Acid
ethacrynate
ETHACRYNIC ACID
Ethacrynic acid (USP)
Ethacrynic acid [USAN:BAN]
Ethacrynic acid [USAN:USP]
Ethacrynic acid, >=97% (HPLC)
Ethacrynic acid, European Pharmacopoeia (EP) Reference Standard
Ethacrynic Acid, Sodium Salt
Ethacrynic acid, United States Pharmacopeia (USP) Reference Standard
Ethacrynicacid
FT-0603245
GTPL7179
Hidromedin
HMS1568D20
HMS1920M16
HMS2089N17
HMS2091D17
HMS2095D20
HMS3259G03
HMS502M22
HSDB 2136
Hydromedin
IDI1_000900
KB-226863
KBio1_000900
KBio2_001293
KBio2_003861
KBio2_006429
KBio3_001230
KBioGR_001207
KBioSS_001293
KS-000017ZX
KS-1453
Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova
Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova [Czech]
Kyselina ethakrynova
Kyselina ethakrynova [Czech]
LS-240
M5DP350VZV
MCULE-6140194266
Methylenebutyryl phenoxyacetic acid
Methylenebutyrylphenoxyacetic acid
MFCD00056693
Mingit
MK 595
MK-595
MLS000069535
MLS002548854
MLS002701928
MolPort-003-666-185
N-ALPHA-CARBOBENZOXY-L-ASPARTIC ACID ALPHA-T-BUTYL
NC00450
NCGC00016260-01
NCGC00016260-02
NCGC00016260-03
NCGC00016260-04
NCGC00016260-05
NCGC00016260-06
NCGC00016260-07
NCGC00016260-08
NCGC00016260-09
NCGC00016260-10
NCGC00016260-11
NCGC00016260-13
NCGC00022601-03
NCGC00022601-04
NCGC00022601-05
NCGC00258654-01
NCI60_041898
NINDS_000900
NSC 624008
NSC 85791
NSC-624008
NSC-757026
NSC-85791
NSC624008
NSC757026
NSC85791
Opera_ID_61
OR065850
OR289736
Otacril
Pharmakon1600-01500287
Prestwick_671
Prestwick0_000259
Prestwick1_000259
Prestwick2_000259
Prestwick3_000259
Reomax
RTR-020341
SAM002264611
SBB064161
SBI-0051374.P003
SC-34221
SC-74303
SCHEMBL26353
SMR000058600
SPBio_000054
SPBio_002297
Spectrum_000813
SPECTRUM1500287
Spectrum2_000097
Spectrum3_000425
Spectrum4_000544
Spectrum5_000680
SR-01000003010
SR-01000003010-2
Taladren
Tox21_110335
Tox21_110335_1
Tox21_201102
TR-020341
UNII-M5DP350VZV
Uregit
V0310
WLN: QV1OR BG CG DVY2&U1
ZINC1382

US Patents and Regulatory Information for EDECRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton EDECRIN ethacrynate sodium INJECTABLE;INJECTION 016093-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aton EDECRIN ethacrynic acid TABLET;ORAL 016092-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aton EDECRIN ethacrynic acid TABLET;ORAL 016092-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
Teva
Medtronic
Covington
Baxter
McKinsey
McKesson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.